Sales reps can now ask AcuityAI about recent procedure activity to uncover emerging trends and identify physicians for outreach

AcuityMD, the AI platform for MedTech, today announced the availability of Early Signals in AcuityAI, giving commercial teams earlier visibility into potential changes in healthcare provider (HCP) procedure activity. Drawing on recent medical claims data, AcuityAI can identify early indicators that a physician may have started performing a procedure they had not performed previously. This intelligence also helps sales reps target new physicians and engage them ahead of competitors, building relationships as surgeons expand into new procedures.

MedTech sales teams rely on procedure data to understand physician behavior but traditional claims reporting can take months to reflect changes in physician activity, leaving reps with limited visibility into emerging market trends. With Early Signals now available in AcuityAI, reps can simply ask questions about recent procedure activity and get directional insights without waiting for fully adjudicated claims data to become available.

"Timing matters in MedTech sales. When a physician begins performing a new procedure, that can be an important signal for a rep to reach out and better understand what's changing in their practice," said Brian Collins, Chief Product Officer at AcuityMD. "One of the things we consistently hear from sales teams is how valuable timely information is to their success. The sooner reps understand what may be changing in their territory, the sooner they can investigate and then adjust their priorities. Bringing Early Signals into AcuityAI makes that intelligence easier and faster to access."

Early Signals is now available within AcuityAI for AcuityMD customers. More information can be found at acuitymd.com/platform/medtech-ai-platform.

About AcuityMD

AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies – including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD ranked No. 316 on the 2026 Inc. 5000 list of the fastest-growing private companies in America and was named to Forbes’ 2025 “Next Billion-Dollar Startups” list – an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261110717920/en/

The sooner MedTech sales reps understand what may be changing in their territory, the sooner they can investigate and then adjust their priorities. Bringing Early Signals into AcuityAI makes that intelligence easier and faster to access.